{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:44:14Z","timestamp":1793148254416,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ccc.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T12:51:48Z","timestamp":1540471908000},"page":"169-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Complications of Solid Organ Transplantation"],"prefix":"10.1016","volume":"35","author":[{"given":"Ayan","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelisa","family":"Callisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Libricz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.ccc.2018.08.011_bib1","first-page":"S4","article-title":"Solid organ transplantation overview and delection criteria","volume":"21","author":"Kellar","year":"2015","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ccm.2005.06.002","article-title":"An overview of solid organ transplantation","volume":"26","author":"Bloom","year":"2005","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccc.2008.12.001","article-title":"History of solid organ transplantation and organ donation","volume":"25","author":"Linden","year":"2009","journal-title":"Crit Care Clin"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamasurg.2014.2038","article-title":"Survival benefit of solid-organ transplant in the United States","volume":"150","author":"Rana","year":"2015","journal-title":"JAMA Surg"},{"issue":"5 Suppl 3","key":"10.1016\/j.ccc.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mcna.2016.01.004","article-title":"Managing cardiovascular risk in the post solid organ transplant recipient","volume":"100","author":"Munagala","year":"2016","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trre.2013.12.001","article-title":"Cardiovascular complications after transplantation: treatment options in solid organ recipients","volume":"28","author":"Gillis","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","article-title":"Predicting coronary heart disease after kidney transplantation: patient outcomes in renal transplantation (PORT) study","volume":"10","author":"Israni","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1681\/ASN.2005090984","article-title":"Acute myocardial infarction and kidney transplantation","volume":"17","author":"Kasiske","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1681\/ASN.2004070580","article-title":"Incidence and predictors of myocardial infarction after kidney transplantation","volume":"16","author":"Lentine","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","article-title":"Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation","volume":"98","author":"Tiukinhoy-Laing","year":"2006","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ccc.2018.08.011_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/TP.0b013e318247a782","article-title":"Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients","volume":"93","author":"Boggi","year":"2012","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.ccc.2018.08.011_bib13","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.27.7.1706","article-title":"Pancreas transplantation improves vascular disease in patients with type 1 diabetes","volume":"27","author":"Larsen","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1183\/09031936.04.00065004","article-title":"Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness","volume":"24","author":"Studer","year":"2004","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1053-2498(02)00498-9","article-title":"The registry of the International Society for Heart and Lung Transplantation: nineteenth official report-2002","volume":"21","author":"Hertz","year":"2002","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48\u00a0months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/TP.0b013e31820c10eb","article-title":"Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies)","volume":"91","author":"Vanrenterghem","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib20","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfp581","article-title":"Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET","volume":"25","author":"Philipp","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib22","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","article-title":"Improved long-term outcomes after renal transplantation associated with blood pressure control","volume":"5","author":"Opelz","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.ccc.2018.08.011_bib23","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib24","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients","author":"Pascual","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","article-title":"Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys","volume":"12","author":"Pestana","year":"2012","journal-title":"Am J Transplant"},{"issue":"9756","key":"10.1016\/j.ccc.2018.08.011_bib26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Symplicity","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2018.08.011_bib27","doi-asserted-by":"crossref","first-page":"022","DOI":"10.23937\/2572-4045.1510022","article-title":"Complications after heart transplantation: hope for the best, but prepare for the worst","volume":"2","author":"Alba","year":"2016","journal-title":"Int J Transplant Res Med"},{"key":"10.1016\/j.ccc.2018.08.011_bib28","series-title":"Clinical lipidology: a companion to Braunwald's heart disease; special populations: transplant recipients","author":"Ballantyne","year":"2009"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0012.2004.00160.x","article-title":"A\u00a0long-term study on hyperlipidemia in stable renal transplant recipients","volume":"18","author":"Tse","year":"2004","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ki.1996.69","article-title":"Increased low density lipoprotein oxidation in stable kidney transplant recipients","volume":"49","author":"Ghanem","year":"1996","journal-title":"Kidney Int"},{"issue":"5 Suppl 3","key":"10.1016\/j.ccc.2018.08.011_bib31","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1053\/ajkd.1998.v32.pm9820472","article-title":"Hyperlipidemia in patients with chronic renal disease","volume":"32","author":"Kasiske","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ccc.2018.08.011_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1034\/j.1600-6143.2002.20610.x","article-title":"Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model","volume":"2","author":"Blum","year":"2002","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ccc.2018.08.011_bib33","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"issue":"9784","key":"10.1016\/j.ccc.2018.08.011_bib34","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib35","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1600-6143.2012.04101.x","article-title":"Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial","volume":"12","author":"Weiner","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","article-title":"Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival","volume":"3","author":"Cole","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1523-1755.2001.059002732.x","article-title":"Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2010.09.003","article-title":"New-onset diabetes after transplantation: risk factors and clinical impact","volume":"37","author":"Rakel","year":"2011","journal-title":"Diabetes Metab"},{"issue":"6","key":"10.1016\/j.ccc.2018.08.011_bib40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.ccc.2018.08.011_bib42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","article-title":"Posttransplantation diabetes: a systematic review of the literature","volume":"25","author":"Montori","year":"2002","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.ccc.2018.08.011_bib44","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/TP.0b013e318276a20e","article-title":"Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial","volume":"95","author":"Werzowa","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0012.2005.00359.x","article-title":"Guidelines for the treatment and management of new-onset diabetes after transplantation","volume":"19","author":"Wilkinson","year":"2005","journal-title":"Clin Transplant"},{"issue":"24","key":"10.1016\/j.ccc.2018.08.011_bib47","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib48","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/TP.0b013e31816f1b7c","article-title":"Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation","volume":"85","author":"Oufroukhi","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A\u00a0phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ccc.2018.08.011_bib51","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/TP.0b013e31819e3f14","article-title":"Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review","volume":"87","author":"Modanlou","year":"2009","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib52","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/ajt.12829","article-title":"Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation","volume":"14","author":"Golomb","year":"2014","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ccc.2018.08.011_bib53","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ccc.2018.08.011_bib55","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","article-title":"Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era","volume":"84","author":"Nwakanma","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00001573-200403000-00018","article-title":"Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy","volume":"19","author":"Fishbein","year":"2004","journal-title":"Curr Opin Cardiol"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report\u20142013; focus theme: age","volume":"32","author":"Lund","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib59","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.healun.2015.08.014","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report--2015; focus theme: early graft failure","volume":"34","author":"Yusen","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib60","first-page":"319","article-title":"Cardiac allograft vasculopathy: a review","volume":"48","author":"Ramzy","year":"2005","journal-title":"Can J Surg"},{"issue":"7","key":"10.1016\/j.ccc.2018.08.011_bib61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010","volume":"29","author":"Mehra","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.ccc.2018.08.011_bib62","first-page":"1024","article-title":"Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography","volume":"13","author":"Akosah","year":"1994","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib63","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.hrthm.2014.07.016","article-title":"Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation","volume":"11","author":"Vakil","year":"2014","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib64","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.ccc.2018.08.011_bib65","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/ajt.13214","article-title":"The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a Scandinavian randomized trial","volume":"15","author":"Arora","year":"2015","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ccc.2018.08.011_bib66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jchf.2013.07.002","article-title":"Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the everolimus versus mycophenolate mofetil randomized, multicenter trial","volume":"1","author":"Kobashigawa","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1432-2277.2008.00780.x","article-title":"Neurologic complications after solid organ transplantation","volume":"22","author":"Senzolo","year":"2009","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib68","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ncl.2017.06.013","article-title":"Neurologic complications of solid organ transplantation","volume":"35","author":"Pizzi","year":"2017","journal-title":"Neurol Clin"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib69","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1590\/0004-282x20170132","article-title":"Neurological complications of solid organ transplantation","volume":"75","author":"Pedroso","year":"2017","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ncl.2011.07.002","article-title":"Central nervous system complications after transplantation","volume":"29","author":"Dhar","year":"2011","journal-title":"Neurol Clin"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib71","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/WNL.45.11.1962","article-title":"Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression","volume":"45","author":"Wijdicks","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0012.2000.140101.x","article-title":"Central nervous system complications in\u00a0liver transplant recipients--incidence, timing, and long-term follow-up","volume":"14","author":"Bronster","year":"2000","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib73","first-page":"170","article-title":"Neurotoxicity of immunosuppressive therapies in organ transplantation","volume":"8","author":"Anghel","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.ccc.2018.08.011_bib74","doi-asserted-by":"crossref","first-page":"642108","DOI":"10.1155\/2012\/642108","article-title":"Pathogenesis of hepatic encephalopathy","volume":"2012","author":"Ciecko-Michalska","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib75","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/01.WNL.0000089487.42870.C6","article-title":"Neurologic complications of liver transplantation in adults","volume":"61","author":"Lewis","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ccc.2018.08.011_bib76","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/TP.0b013e318280b359","article-title":"Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome","volume":"95","author":"Shigemura","year":"2013","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ccc.2018.08.011_bib77","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jocn.2015.03.006","article-title":"Central nervous system complications after liver transplantation","volume":"22","author":"Kim","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0733-8619(18)30868-5","article-title":"Infection of the central nervous system in organ transplant recipients","volume":"6","author":"Conti","year":"1988","journal-title":"Neurol Clin"},{"issue":"12","key":"10.1016\/j.ccc.2018.08.011_bib79","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/archneur.64.12.noc70065","article-title":"Central nervous system infections in heart transplant recipients","volume":"64","author":"van de Beek","year":"2007","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0885066610389549","article-title":"Neurological complications of transplantation","volume":"26","author":"Pustavoitau","year":"2011","journal-title":"J\u00a0Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib81","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340310791658811","article-title":"Cerebrovascular complications after heart transplantation","volume":"6","author":"Alejaldre","year":"2010","journal-title":"Curr Cardiol Rev"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib82","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0733-8619(18)30870-3","article-title":"Seizures and antiepileptic drug use in transplant patients","volume":"6","author":"Gilmore","year":"1988","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.ccc.2018.08.011_bib84","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.410360503","article-title":"Neurological complications of organ transplantation","volume":"36","author":"Patchell","year":"1994","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib85","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12028-010-9470-y","article-title":"Neurological management of fulminant hepatic failure","volume":"14","author":"Frontera","year":"2011","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1016\/j.ccc.2018.08.011_bib86","doi-asserted-by":"crossref","first-page":"139","DOI":"10.12659\/AOT.882008","article-title":"Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation","volume":"16","author":"Fukazawa","year":"2011","journal-title":"Ann Transplant"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib87","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00007890-199602270-00026","article-title":"Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation","volume":"61","author":"Fryer","year":"1996","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.ackd.2005.10.007","article-title":"Chronic kidney disease in solid-organ transplantation","volume":"13","author":"Miller","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib89","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2215\/CJN.02950410","article-title":"An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation","volume":"5","author":"Srinivas","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib90","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/ndt\/gfl247","article-title":"Chronic kidney disease post-liver transplantation","volume":"21","author":"O'Riordan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12882-017-0657-8","article-title":"Temporal trends of dialysis requiring acute kidney injury after orthotopic cardiac and liver transplant hospitalizations","volume":"18","author":"Nadkarni","year":"2017","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1016\/j.ccc.2018.08.011_bib92","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.healun.2011.04.013","article-title":"Severe acute kidney injury according to the RIFLE (risk, injury, failure, loss, end stage) criteria affects mortality in lung transplantation","volume":"30","author":"Arnaoutakis","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccc.2018.08.011_bib93","series-title":"Renal function and nonrenal solid organ transplantation","author":"Bloom","year":"2016"},{"issue":"6","key":"10.1016\/j.ccc.2018.08.011_bib94","first-page":"1355","article-title":"Implications of acute kidney injury after heart transplantation: what a surgeon should know","volume":"40","author":"De Santo","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib95","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/TP.0000000000001030","article-title":"Acute kidney injury and outcome after heart transplantation: large differences in performance of scoring systems","volume":"100","author":"Schiferer","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ccc.2018.08.011_bib96","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/lt.24728","article-title":"Hepatic ischemia\/reperfusion injury associates with acute kidney injury in liver transplantation: prospective cohort study","volume":"23","author":"Jochmans","year":"2017","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.ccc.2018.08.011_bib97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000168123","article-title":"The spectrum of ciclosporin nephrotoxicity","volume":"10","author":"Puschett","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ccc.2018.08.011_bib98","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/DDDT.S149340","article-title":"Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis","volume":"12","author":"Xia","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.ccc.2018.08.011_bib99","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.transproceed.2010.08.042","article-title":"The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience","volume":"42","author":"Bacchi","year":"2010","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib101","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ajt.12543","article-title":"De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial","volume":"14","author":"Asrani","year":"2014","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib102","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/j.1600-6143.2010.03292.x","article-title":"Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients","volume":"10","author":"Cassuto","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ccc.2018.08.011_bib103","series-title":"Practical gastroenterology and hepatology board review toolkit","first-page":"419","article-title":"Gastrointestinal complications of solid organ and hematopoietic cell transplantation","author":"Chandok","year":"2016"},{"issue":"5","key":"10.1016\/j.ccc.2018.08.011_bib104","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.suc.2006.06.006","article-title":"Gastrointestinal complications following transplantation","volume":"86","author":"Gautam","year":"2006","journal-title":"Surg Clin North Am"},{"issue":"5","key":"10.1016\/j.ccc.2018.08.011_bib105","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.suc.2006.06.005","article-title":"Infections complicating solid organ transplantation","volume":"86","author":"Fischer","year":"2006","journal-title":"Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1399-3062.1999.10103.x","article-title":"Infection in solid organ transplantation","volume":"1","author":"Snydman","year":"1999","journal-title":"Transpl Infect Dis"},{"issue":"19","key":"10.1016\/j.ccc.2018.08.011_bib107","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"Lowance","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccc.2018.08.011_bib108","first-page":"140","article-title":"Management of hepatitis C post-liver transplantation: a comprehensive review","volume":"3","author":"Mitchell","year":"2015","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"11","key":"10.1016\/j.ccc.2018.08.011_bib109","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1600-6143.2008.02362.x","article-title":"Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection","volume":"8","author":"Veldt","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ccc.2018.08.011_bib110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9610(91)90108-P","article-title":"Peptic ulcer disease following renal transplantation in the cyclosporine era","volume":"162","author":"Reese","year":"1991","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.ccc.2018.08.011_bib111","first-page":"63","article-title":"Colonic perforations after renal transplantation","volume":"184","author":"Stelzner","year":"1997","journal-title":"J\u00a0Am Coll Surg"},{"issue":"8","key":"10.1016\/j.ccc.2018.08.011_bib112","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070418307498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070418307498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:06:00Z","timestamp":1760061960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070418307498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0749070418307498"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2018.08.011","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications of Solid Organ Transplantation","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}